DTC Report: DTC Gets Smart
DTC Report: 10 Riskiest DTC Ads Ever
Rare Diseases: Orphans in Danger
Therapeutic Focus 2014: Respiratory
Headliner: Pharma's type "A" exec—and mentor
Non-Personal Promotion: A New Era in E-Sampling
Read the 2014 Game Changers digital edition
Skill Sets Live: Content Marketing for Healthcare
A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.
US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.
Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also reaped blockbuster sales for Gilead.
The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.
What brand managers need to know to achieve data security maturity
Express Scripts warned of building an anti-Sovaldi coalition. If payers are unwilling to pay for such drugs, or band against their makers, where does pharma go from here?
Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.
The company expects to file an sNDA for plaque psoriasis next year.
Sales rose 5% compared to the same period last year.
Click on the image above to see a gallery of images from the 2013 MM&M Awards dinner
The new MM&M e-book, "Oncology Marketing," is designed to serve as a companion for those in the business of communicating cancer products to all three stakeholders. It's packed with analysis, advice, insights and commentary to help navigate the terrain. Click here to access it.